Cleared Traditional

K891481 - SIEMENS SIRECUST TRANSCUTANEOUS CARBON DIOXIDE

K891481 is an FDA 510(k) clearance for SIEMENS SIRECUST TRANSCUTANEOUS CARBON ..., manufactured by Siemens Medical Electronics. The device is a Class 2 Anesthesiology device with product code LKD cleared through the Traditional 510(k) pathway after a 196-day FDA review.

K891481 · Siemens Medical Electronics · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1989
Decision
196d
Days
Class 2
Risk

K891481 is an FDA 510(k) clearance for the SIEMENS SIRECUST TRANSCUTANEOUS CARBON DIOXIDE. Classified as Monitor, Carbon-dioxide, Cutaneous (product code LKD), Class II - Special Controls.

Submitted by Siemens Medical Electronics (Danvers, US). The FDA issued a Cleared decision on September 29, 1989 after a review of 196 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.2480 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Siemens Medical Electronics devices

FDA 510(k) Submission Details - K891481

510(k) Number K891481 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 17, 1989
Decision Date September 29, 1989
Days to Decision 196 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
56d slower than avg
Panel avg: 140d · This submission: 196d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LKD Device Classification - Class 2, Special Controls

Product Code LKD Monitor, Carbon-dioxide, Cutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.2480
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - LKD Monitor, Carbon-dioxide, Cutaneous

All 14
Devices cleared under the same product code (LKD) and FDA review panel - the closest regulatory comparables to K891481.
COROMETRICS TRANSCUTANEOUS TCPO2/CO2 MODULE
K980756 · Ge Medical Systems Information Technologies · Nov 1998
TCPO2 9260 MODULE - SYSTEM ATHENA
K913013 · S & W Medico Teknik · May 1994
E5280 COMBINED TRANSCUTANEOUS TCP02/TCPCO2 ELECT.
K900333 · Radiometer America, Inc. · Apr 1990
TRANSCUTANEOUS O2/CO2 MONITOR
K890517 · Novametrix Medical Systems, Inc. · Apr 1989
MODEL HP 15209A TRANS. COMBINED TCP02/TCPCO2 TRANS
K883606 · Hewlett-Packard Co. · Dec 1988